Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
about
Chronic myeloid leukemia: reminiscences and dreamsIs imatinib a prototypical example of targeted drug therapy?Advances in studies of tyrosine kinase inhibitors and their acquired resistance.Potential of Bacillus subtilis lipopeptides in anti-cancer I: induction of apoptosis and paraptosis and inhibition of autophagy in K562 cells.
P2860
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
@en
type
label
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
@en
prefLabel
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
@en
P2860
P1476
Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
@en
P2093
Victoria E Mgbemena
P2860
P304
P356
10.4161/23723548.2014.963450
P577
2014-07-01T00:00:00Z